Ardent Health, Inc. (ARDT) EBITDA

Annual EBITDA:

$563.07M+$192.73M(+52.04%)
December 31, 2024

Summary

  • As of today, ARDT annual EBITDA is $563.07 million, with the most recent change of +$192.73 million (+52.04%) on December 31, 2024.
  • During the last 3 years, ARDT annual EBITDA has risen by +$103.15 million (+22.43%).
  • ARDT annual EBITDA is now at all-time high.

Performance

1-Year Change

+52.04%

3-Year Change

+22.43%

5-Year Change

+22.43%

15-Year Change

+145.08%

ARDT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

91.94%
ARDT annual EBITDA is higher than 91.94% of companies in Healthcare sector

Range

All-Time High

$563.07M
ARDT annual EBITDA is currently at an all-time high

3-Year Low

$337.28M
ARDT annual EBITDA is currently +66.94% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ARDT previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 4, 2026
ARDT next annual earnings announcement is scheduled for Mar 4, 2026

OtherARDTincome statement metrics

Annual Revenue

$5.97B
ARDT annual revenue is $5.97 billion

Annual Net Income

$299.71M
ARDT annual net profit is $299.71 million

Annual EBIT

$416.79M
ARDT annual earnings before interest & taxes is $416.79 million

Annual EPS

$1.47
ARDT annual earnings per share is $1.47

Quarterly EBITDA:

$55.61M-$125.76M(-69.34%)
September 30, 2025

Summary

  • As of today, ARDT quarterly EBITDA is $55.61 million, with the most recent change of -$125.76 million (-69.34%) on September 30, 2025.
  • Over the past year, ARDT quarterly EBITDA has dropped by -$55.82 million (-50.09%).
  • ARDT quarterly EBITDA is now -70.95% below its all-time high of $191.47 million, reached on December 31, 2024.

Performance

3-Month Change

-69.34%

1-Year Change

-50.09%

3-Year Change

-37.41%

5-Year Change

-37.41%

ARDT Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

86.34%
ARDT quarterly EBITDA is higher than 86.34% of companies in Healthcare sector

Range

All-Time High

$191.47M
ARDT quarterly EBITDA is currently -70.95% below its historical high of $191.47 million

3-Year Low

$55.61M
ARDT quarterly EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ARDT previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 4, 2026
ARDT next earnings announcement is scheduled for Mar 4, 2026

OtherARDTincome statement metrics

Quarterly Revenue

$1.58B
ARDT quarterly revenue is $1.58 billion

Quarterly Net Income

$1.21M
ARDT quarterly net profit is $1.21 million

Quarterly EBIT

$16.46M
ARDT quarterly earnings before interest & taxes is $16.46 million

Quarterly EPS

-$0.17
ARDT quarterly earnings per share is -$0.17

TTM EBITDA:

$533.41M-$55.82M(-9.47%)
September 30, 2025

Summary

  • As of today, ARDT TTM EBITDA is $533.41 million, with the most recent change of -$55.82 million (-9.47%) on September 30, 2025.
  • Over the past year, ARDT TTM EBITDA has increased by +$98.59 million (+22.67%).
  • ARDT TTM EBITDA is now -9.47% below its all-time high of $589.23 million, reached on June 30, 2025.

Performance

3-Month Change

-9.47%

1-Year Change

+22.67%

3-Year Change

+500.35%

5-Year Change

+500.35%

ARDT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

90.75%
ARDT TTM EBITDA is higher than 90.75% of companies in Healthcare sector

Range

All-Time High

$589.23M
ARDT TTM EBITDA is currently -9.47% below its historical high of $589.23 million

3-Year Low

$88.85M
ARDT TTM EBITDA is currently +500.35% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ARDT previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 4, 2026
ARDT next earnings announcement is scheduled for Mar 4, 2026

OtherARDTincome statement metrics

TTM Revenue

$6.33B
ARDT TTM revenue is $6.33 billion

TTM Net Income

$296.76M
ARDT TTM net profit is $296.76 million

TTM EBIT

$380.89M
ARDT TTM earnings before interest & taxes is $380.89 million

TTM EPS

$1.44
ARDT TTM earnings per share is $1.44

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$563.07M
ARDT annual EBITDA is $563.07 million

Annual Net Income

$299.71M
ARDT annual net profit is $299.71 million

Annual Interest Expense

$0.00
ARDT annual interest expense is $0.00

Annual Income Tax

$63.35M
ARDT annual income tax is $63.35 million

Annual D&A

$146.29M
ARDT annual D&A is $146.29 million

ARDT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+52.0%-50.1%+22.7%
3Y3 Years+22.4%-37.4%+500.4%
5Y5 Years+22.4%-37.4%+500.4%

ARDT EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+66.9%-71.0%at low-9.5%+500.4%
5Y5-Yearat high+99.8%-71.0%at low-9.5%+500.4%
All-TimeAll-Timeat high+260.3%-71.0%at low-9.5%+608.7%

ARDT EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$55.61M(-69.3%)
$533.41M(-9.5%)
Jun 2025
-
$181.38M(+72.8%)
$589.23M(+6.3%)
Mar 2025
-
$104.94M(-45.2%)
$554.12M(-1.6%)
Dec 2024
$563.07M(+52.0%)
$191.47M(+71.8%)
$563.28M(+29.5%)
Sep 2024
-
$111.43M(-23.8%)
$434.81M(+2.1%)
Jun 2024
-
$146.27M(+28.2%)
$425.83M(+7.6%)
Mar 2024
-
$114.11M(+81.1%)
$395.60M(+6.8%)
Dec 2023
$370.35M
$63.01M(-38.5%)
$370.34M(+20.5%)
Sep 2023
-
$102.45M(-11.7%)
$307.34M(+50.0%)
DateAnnualQuarterlyTTM
Jun 2023
-
$116.04M(+30.6%)
$204.89M(+130.6%)
Mar 2023
-
$88.85M(+3.6%)
$88.85M(-49.4%)
Dec 2022
$337.28M(-26.7%)
-
-
Dec 2021
$459.93M(+63.2%)
-
-
Dec 2018
$281.84M(+22.7%)
$85.76M(-4.5%)
$175.57M(+6.4%)
Sep 2018
-
$89.81M(+19.3%)
$165.07M(+119.3%)
Dec 2017
$229.75M(+47.0%)
$75.27M
$75.27M
Dec 2016
$156.27M(-27.6%)
-
-
Dec 2015
$215.91M
-
-

FAQ

  • What is Ardent Health, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Ardent Health, Inc.?
  • What is Ardent Health, Inc. annual EBITDA year-on-year change?
  • What is Ardent Health, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Ardent Health, Inc.?
  • What is Ardent Health, Inc. quarterly EBITDA year-on-year change?
  • What is Ardent Health, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Ardent Health, Inc.?
  • What is Ardent Health, Inc. TTM EBITDA year-on-year change?

What is Ardent Health, Inc. annual EBITDA?

The current annual EBITDA of ARDT is $563.07M

What is the all-time high annual EBITDA for Ardent Health, Inc.?

Ardent Health, Inc. all-time high annual EBITDA is $563.07M

What is Ardent Health, Inc. annual EBITDA year-on-year change?

Over the past year, ARDT annual EBITDA has changed by +$192.73M (+52.04%)

What is Ardent Health, Inc. quarterly EBITDA?

The current quarterly EBITDA of ARDT is $55.61M

What is the all-time high quarterly EBITDA for Ardent Health, Inc.?

Ardent Health, Inc. all-time high quarterly EBITDA is $191.47M

What is Ardent Health, Inc. quarterly EBITDA year-on-year change?

Over the past year, ARDT quarterly EBITDA has changed by -$55.82M (-50.09%)

What is Ardent Health, Inc. TTM EBITDA?

The current TTM EBITDA of ARDT is $533.41M

What is the all-time high TTM EBITDA for Ardent Health, Inc.?

Ardent Health, Inc. all-time high TTM EBITDA is $589.23M

What is Ardent Health, Inc. TTM EBITDA year-on-year change?

Over the past year, ARDT TTM EBITDA has changed by +$98.59M (+22.67%)
On this page